Pathologic Mammography Findings in Symptomatic and Asymptomatic Patients in a Nigerian Population

Daniel Chimuanya Ugwuanyi; Egwuonwu Victor Afamefuna

doi:10.31149/ijimm.v4i4.2852

Authors

Daniel Chimuanya Ugwuanyi Department of Radiography and Radiological Sciences, Faculty of Health Sciences and Technology, Nnamdi Azikiwe University, Nnewi Campus, Anambra State, Nigeria
Egwuonwu Victor Afamefuna Department of Medical Rehabilitation (Physiotherapy), Faculty of Health Sciences, Nnamdi Azikiwe University, Nnewi Campus, Nigeria

DOI:

https://doi.org/10.31149/ijimm.v4i4.2852

Keywords:

Breast Screening, Mammography, Breast Health, Diagnostic Imaging, Early Detection, Radiodianostic Centres, Imo State

Abstract

Breast cancer is a serious and harmful disease. It has therefore become pertinent to undergo annual mammography screenings or check-ups when abnormal changes are suspected, ensuring that both women and men are adequately protected from the detrimental effects of breast cancer before it metastasizes. The purpose of this study was to compare the pathologic mammography findings in symptomatic and asymptomatic patients in a Nigerian population. A total of 154 mammography data were collected by the researcher, analyzed, and inferences were made based on the results. The research design adopted was a retrospective study. The sample size of 154 was obtained from patients’ request cards and radiologic reports stored in the diagnostic centres’ information systems. Among the data collected, 3 were male and 151 were female. The most frequent clinical indication presented was mastodynia (breast pain), with a frequency of 61. The most common age group was 44–53 years. Radiologic findings were predominantly normal in 121 cases (78.6%). Based on BIRADS classification, the most common category was BIRADS I (normal), occurring in 84 cases (54.5%). Among asymptomatic patients, the predominant finding was normal, while in symptomatic patients, calcifications were most commonly observed.

References

[1] A. L. Jannetta, Advanced Deconvolution Techniques and Medical Radiography. Newcastle, U.K.: Univ. of Northumbria, 2005.

[2] R. M. Reilly, Ed., Medical Imaging for Health Professionals: Technologies and Clinical Applications. Hoboken, NJ, USA: John Wiley & Sons, 2019.

[3] K. C. Oeffinger et al., “Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society,” JAMA, vol. 314, no. 15, pp. 1599–1614, 2015.

[4] G. I. Balali, “Breast cancer: A review of mammography and clinical breast examination for early detection,” Open Access Library Journal, vol. 7, no. 10, p. 1, 2020.

[5] G. Bistoni et al., “Anatomy and physiology of the breast,” Surgery (Oxford), vol. 42, no. 12, pp. 859–864, 2024.

[6] B. Jasra, S. Sharma, and A. Deladisma, “Evaluating patients with breast concerns: Lump, pain, and mastitis,” SAT, vol. 19, p. 23, 2023.

[7] E. I. Obeagu and G. U. Obeagu, “Breast cancer: A review of risk factors and diagnosis,” Medicine, vol. 103, no. 3, p. e36905, 2024.

[8] C. Comparetto and F. Borruto, “Cutting-edge imaging breakthroughs for early breast cancer detection,” Cancer Screening and Prevention, vol. 4, no. 1, pp. 21–39, 2025.

[9] N. S. Winkler, S. Raza, M. Mackesy, and R. L. Birdwell, “Breast density: Clinical implications and assessment methods,” Radiographics, vol. 35, no. 2, pp. 316–324, 2015.

[10] F. Kakulas and D. Geddes, “Anatomy of the human mammary gland: Current status of knowledge,” Journal of Clinical Anatomy, vol. 26, no. 1, pp. 29–48, 2013.

[11] N. F. Boyd et al., “Breast tissue composition and susceptibility to breast cancer,” JNCI: Journal of the National Cancer Institute, vol. 102, no. 16, 2010.

[12] S. S. Nazari and P. Mukherjee, “An overview of mammographic density and its association with breast cancer,” Breast Cancer, vol. 25, no. 3, pp. 259–267, 2018.

[13] K. Ghosh et al., “Tissue composition of mammographically dense and non-dense breast tissue,” Breast Cancer Research and Treatment, vol. 131, no. 1, pp. 267–275, 2012.

[14] L. Straub et al., “Mammographic density and vitamin D levels—A cross-sectional study,” Geburtshilfe und Frauenheilkunde, vol. 77, no. 3, pp. 257–267, 2017.

[15] [15] G. Curigliano and C. Criscitiello, “Successes and limitations of targeted cancer therapy in breast cancer,” 2014.

[16] [16] N. Kumar et al., “The unique risk factor profile of triple-negative breast cancer: A comprehensive meta-analysis,” JNCI: Journal of the National Cancer Institute, vol. 116, no. 8, pp. 1210–1219, 2024.

[17] T. D. Hill, H. J. Khamis, J. E. Tyczynski, and H. J. Berkel, “Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival,” Annals of Epidemiology, vol. 15, no. 10, pp. 773–780, 2005.

[18] E. R. U. Ebubedike et al., “Pattern of mammographic findings among symptomatic females referred for mammography in South East Nigeria,” West African Journal of Radiology, vol. 23, pp. 23–27, 2016.

[19] O. A. Egwuonwu et al., “Breast pain: Clinical pattern and aetiology in a breast clinic in Eastern Nigeria,” Nigerian Journal of Surgery, 2016.

[20] G. Vivod, S. Merlo, and N. Kovacevic, “High-grade serous ovarian cancer during pregnancy: From diagnosis to treatment,” Current Oncology, vol. 31, no. 4, pp. 1920–1935, 2024.

[21] M. G. Cerdas et al., “Exploring the evolution of breast cancer imaging: A review of conventional and emerging modalities,” Cureus, vol. 17, no. 4, 2025.